Clinical Review
State of the Art Review
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l5887 (Published 05 November 2019) Cite this as: BMJ 2019;367:l5887
Data supplement
Web extra
- Data Supplement - Supplementary table and figures
Related articles
- Research Published: 11 March 2015; BMJ 350 doi:10.1136/bmj.h949
- Research Published: 30 July 2013; BMJ 347 doi:10.1136/bmj.f4533
- Paper Published: 12 August 2000; BMJ 321 doi:10.1136/bmj.321.7258.405
- Education And Debate Published: 24 June 2000; BMJ 320 doi:10.1136/bmj.320.7251.1720
- Analysis Published: 11 August 2009; BMJ 339 doi:10.1136/bmj.b2803
- Education And Debate Published: 10 March 2005; BMJ 330 doi:10.1136/bmj.330.7491.594
- Research Published: 26 July 2011; BMJ 343 doi:10.1136/bmj.d4169
- Research Published: 08 January 2010; BMJ 340 doi:10.1136/bmj.b4909
- Research Published: 24 November 2011; BMJ 343 doi:10.1136/bmj.d6898
- Practice Published: 11 May 2021; BMJ 373 doi:10.1136/bmj.n1091
- Research Published: 03 October 2022; BMJ 379 doi:10.1136/bmj-2022-070717
See more
- Advances in management of heart failureBMJ April 10, 2024, 385 e077025; DOI: https://doi.org/10.1136/bmj-2023-077025
- Effectiveness and safety of drugs for obesityBMJ March 25, 2024, 384 e072686; DOI: https://doi.org/10.1136/bmj-2022-072686
- Management of chronic pancreatitisBMJ February 26, 2024, 384 e070920; DOI: https://doi.org/10.1136/bmj-2023-070920
- Advances in diagnosis and treatment of bladder cancerBMJ February 12, 2024, 384 e076743; DOI: https://doi.org/10.1136/bmj-2023-076743
- New advances in type 1 diabetesBMJ January 26, 2024, 384 e075681; DOI: https://doi.org/10.1136/bmj-2023-075681
Cited by...
- Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial
- Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort
- Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD
- Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
- Emulating the GRADE Trial Using Real-World Data
- SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
- Glucagon Therapy: A Comparison of Current and Novel Treatments